Eli Lilly (LLY) Other Non-Current Assets (2009 - 2026)

Eli Lilly (LLY) has 18 years of Other Non-Current Assets data on file, last reported at $7.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 19.03% year-over-year to $7.2 billion; the trailing twelve-month figure through Mar 2026 stood at $7.2 billion (up 19.03% YoY), and the FY2025 full-year result was $7.0 billion, up 22.24% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $7.2 billion, up from $7.0 billion in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $7.2 billion in Q1 2026 and bottomed at $4.3 billion in Q1 2022.
• The 5-year median for Other Non-Current Assets is $4.9 billion (2023), against an average of $5.3 billion.
• The widest annual swing landed in 2024, when Other Non-Current Assets gained 4.27%; it then rose 29.03% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $4.3 billion in 2022, then advanced by 15.05% to $5.0 billion in 2023, then rose by 14.63% to $5.7 billion in 2024, then advanced by 22.24% to $7.0 billion in 2025, then rose by 3.42% to $7.2 billion in 2026.
• The last three Other Non-Current Assets figures came in at $7.2 billion (Q1 2026), $7.0 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.

Peer Comparison